Vanguard PRIMECAP Core Fund
VPCCX
NASDAQ- -
USD
- -
- -
- -
- -
(- -)
Recent
price
- -
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Vanguard PRIMECAP Core Fund Investor Shares (VPCCX) is an actively managed open-end mutual fund that invests primarily in U.S. large-cap equities exhibiting both value and growth characteristics; it employs a bottom-up, fundamental research approach with a long-term investment horizon, targeting undervalued companies with competitive moats, nascent growth stories, or turnaround potential. The fund allocates assets across approximately 175 stocks through separately managed sleeves run by five portfolio managers—Theo A. Kolokotrones, Joel P. Fried, Alfred W. Mordecai, M. Mohsin Ansari, and James M. Marchetti—who maintain bold sector overweightings in biotechnology, semiconductors, and pharmaceuticals; top holdings as of late 2025 include Eli Lilly and Company (5.33%), Microsoft Corporation (3.22%), AstraZeneca PLC ADR (3.00%), Flex Ltd. (2.93%), and Alphabet Inc. Class A (2.74%), with sector exposures emphasizing technology (26.14%), healthcare (25.69%), and industrials (16.15%). Managed by PRIMECAP Management Company, founded in 1983 and based in Pasadena, California, in partnership with The Vanguard Group, headquartered in Malvern, Pennsylvania and established in 1975, the fund features low portfolio turnover of 11%, an adjusted expense ratio of 0.44%, and a minimum initial investment of $3,000 for investor shares. In June 2024, Vanguard reopened the PRIMECAP Core Fund to all investors without restriction, ending prior limitations that capped existing shareholders' additional purchases at $25,000 annually since its closure in 2009; this strategic shift followed an assessment confirming sufficient investment capacity to accommodate inflows without compromising objectives. PRIMECAP Management, which has collaborated with Vanguard for nearly 40 years, continues to emphasize independent research and multi-year holding periods of three to five years or longer across its strategies. The fund targets individual and institutional investors seeking differentiated large-blend exposure, primarily in the U.S. market, with total assets under management reaching $13.8 billion as of December 2025.